MIR605

gene
On this page

Also known as hsa-mir-605

Summary

MIR605 (microRNA 605, HGNC:32861) is a microRNA gene on chromosome 10q21.1.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 693190 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32861
Approved symbolMIR605
NamemicroRNA 605
Location10q21.1
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-605
Ensembl geneENSG00000207813
Ensembl biotypemiRNA
Entrez693190
RNAcentralURS000075ABF4 — miRNA, 83 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000385078

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000385078 — 1 exons

ExonStartEnd
ENSE000015000845129957351299655

Expression profiles

Bgee: expression breadth broad, 55 present calls, max score 88.14.

Top tissues by expression

55 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
stomachUBERON:000094588.14gold quality
kidneyUBERON:000211385.20gold quality
adrenal tissueUBERON:001830384.61gold quality
liverUBERON:000210780.55gold quality
adult mammalian kidneyUBERON:000008279.61gold quality
lungUBERON:000204877.69gold quality
nucleus accumbensUBERON:000188277.07gold quality
intestineUBERON:000016076.23gold quality
endometriumUBERON:000129574.79gold quality
heartUBERON:000094873.41gold quality
gastrocnemiusUBERON:000138873.27gold quality
colonUBERON:000115571.49gold quality
esophagogastric junction muscularis propriaUBERON:003584171.24gold quality
bloodUBERON:000017870.65gold quality
heart left ventricleUBERON:000208469.73gold quality
left adrenal glandUBERON:000123469.53gold quality
esophagus mucosaUBERON:000246968.24gold quality
vaginaUBERON:000099668.13gold quality
transverse colonUBERON:000115767.90gold quality
right atrium auricular regionUBERON:000663167.88gold quality
body of uterusUBERON:000985367.72gold quality
tibial arteryUBERON:000761067.18gold quality
popliteal arteryUBERON:000225067.17gold quality
left adrenal gland cortexUBERON:003582567.16gold quality
descending thoracic aortaUBERON:000234566.35gold quality
right adrenal glandUBERON:000123366.24gold quality
ascending aortaUBERON:000149666.11gold quality
left coronary arteryUBERON:000162665.60gold quality
small intestine Peyer’s patchUBERON:000345465.56gold quality
muscle layer of sigmoid colonUBERON:003580565.55gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.49

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 22)

  • MicroRNA miR-605 is transcriptionally activated by p53 interaction with its promotor region, and post-transcriptionally represses Mdm2. (PMID:21217645)
  • There was no significant association of SNPs of miR-149 and miR-605 with lung cancer. (PMID:21671485)
  • miR-605 AG/GG genotype carriers had increased susceptibilities to colorectal cancer and gastric cancer in smokers (PMID:21976437)
  • Single-nucleotide polymorphism in MIRN605 is associated with biochemical recurrence in prostate cancer. (PMID:24740842)
  • MiR-605 directly targets and represses PSMD10 expression. (PMID:25131931)
  • Data indicate that the microRNA miR-605 SNP (rs2043556) modifies the age of cancer onset in Li-Fraumeni syndrome (LFS) patients. (PMID:25683625)
  • MIR605 polymorphisms are associated with the risk of head and neck squamous cell carcinoma. (PMID:27515039)
  • Low miR605 expression is associated with melanoma. (PMID:28656250)
  • EN2 is negatively regulated by miR-605, and down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer (PCa) cells by up-regulating EN2, which leads to PCa development and progression (PMID:28943214)
  • Circular RNA circ-VANGL1 is a competing endogenous RNA which contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. (PMID:30146736)
  • the findings of this meta-analysis did not support an association between miR-605 rs2043556 polymorphism and cancer susceptibility. (PMID:30514199)
  • Current meta-analysis indicate that the miR-605 rs2043556 may decrease susceptibility in Asian populations, especially allelic-G may be a protective factor for cancer in carriers [Meta-analysis]. (PMID:30549993)
  • this study highlights the important roles of BLACAT1/miR-605-3p/VASP axis in glioma progression. (PMID:31093978)
  • miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer. (PMID:31452243)
  • Significant Association of miR-605 rs2043556 with Susceptibility to Breast Cancer. (PMID:31556863)
  • microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients. (PMID:31766967)
  • MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers. (PMID:31778928)
  • SNHG16/miR-605-3p/TRAF6/NF-kappaB feedback loop regulates hepatocellular carcinoma metastasis. (PMID:32436333)
  • CircDDX17 acts as a competing endogenous RNA for miR-605 in breast cancer progression. (PMID:32633371)
  • Hsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome. (PMID:34062414)
  • Long Noncoding RNA LINC01703 Exacerbates the Malignant Properties of Non-Small Cell Lung Cancer by Upregulating MACC1 in a MicroRNA-605-3p-Mediated Manner. (PMID:34493358)
  • MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1. (PMID:39076089)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): selective IgA deficiency disease